Key result
After NOS inhibition with L-NAME, COX-2 inhibition with NS-398 further increased blood pressure by 7 +/- 3 mmHg and decreased renal blood flow by 20%.
Why the study?
Does COX-2 inhibition affect renal perfusion and blood pressure after acute NOS inhibition?
Does COX-2 inhibition affect renal perfusion and blood pressure after acute NOS inhibition?
Acute NOS inhibition unmasks renal vasoconstriction with COX-2 inhibition, suggesting COX-2-derived vasodilator eicosanoids compensate for the acute loss of NO to maintain renal perfusion.
Answers are grounded in this paper and cite their sources.
May worsen BP and renal perfusion after NOS inhibition in this model; hypothesis-generating for compensatory eicosanoid roles in humans.
Cyclooxygenase (COX)-2 is in the macula densa, cosegregating with neuronal nitric oxide synthase (nNOS). It is hypothesized that in response to acute inhibition of NOS, the influence of COX-2-derived prostanoids is exaggerated, compensating for renal vasoconstriction. Blood pressure (BP) and renal blood flow (RBF) were measured after selective COX-2 inhibition with NS-398 followed by NOS inhibition with L-nitro arginine methyl ester (L-NAME) or after L-NAME followed by NS-398. BP was 106 +/- 4 mmHg and was unaffected by NS-398. L-NAME after NS-398 increased BP by 27 +/- 2 mmHg, decreased RBF by one-half, and doubled renal vascular resistance (RVR; P < 0.001). Initial L-NAME increased BP by 26 +/- 3 mmHg (P < 0.001) and decreased RBF by 44% (P < 0.001), doubling RVR. After L-NAME, NS-398 induced a further 7 +/- 3-mmHg rise in BP (P < 0.05), decreased RBF by 20% (P < 0.025), and increased RVR by 23% (P < 0.01). The constrictor response to COX-2 inhibition after L-NAME could not be duplicated by either selective nNOS inhibition or NOS-independent renal vasoconstriction. Acute NOS inhibition unmasked renal vasoconstriction with COX-2 inhibition, suggesting that the influence of COX-2-derived vasodilator eicosanoids is exaggerated to maintain renal perfusion, compensating for the acute loss of NO.
No takes yet. Share an insight, caveat, or question.
William H. Beierwaltes (2002) studied this question. Selective COX-2 inhibition with NS-398 and NOS inhibition with L-NAME vs. Baseline was evaluated on Blood pressure (BP), renal blood flow (RBF), and renal vascular resistance (RVR) (p=<0.05). After NOS inhibition with L-NAME, COX-2 inhibition with NS-398 further increased blood pressure by 7 +/- 3 mmHg and decreased renal blood flow by 20%.
Synapse has enriched 10 related papers. Consider them for comparative context: